Table 2 Relevant fibroblasts (CD90⁺/CD90⁻) involved in some diseases

CD90⁺

Rheumatoid arthritis

Mizoguchiet al. (2018), Varzideh et al. (2022), Kurose et al. (2022)

Inflammatory arthritis

Wei et al. (2020), Onuora (2020)

Inflammatory skin disease

Nazari et al. (2016), Barron et al. (2019)

Pulmonary fibrosis

Pechkovsky et al. (2012), Zhang et al. (2019)

Melanoma

Goldstein et al. (2005)

Esophageal cancer

Krämer et al. (2020)

Colorectal cancer

Tancharoen et al. (2017), Gao et al. (2022)

Renal fibrosis

(Borza et al. 2022; Zheng et al. 2019)

Prostatic cancer

Sauzay et al. (2019), Kwon et al. (2019)

Pancreatic cancer

Ziani et al. (2018), Öhlund et al. (2014), Ding et al. (2018)

Liver cancer

Zhao et al. (2016)

CD90⁻

Pulmonary fibrosis

Celada et al. (2018), Zhang et al. (2019), Yang et al. (2020)